Summary
Industry
Insights
Babylon Health, based in London, has strong potential in the healthcare sector with its AI-powered platform for diagnosis and consultation. By leveraging artificial intelligence, Babylon addresses issues like delayed diagnosis, high costs, and limited access to medical advice. Their business model caters to both individual consumers and organizations, broadening their market reach. The company is backed by several notable investors, ensuring solid financial support for growth. Despite competition from traditional in-person doctor visits and general telemedicine services, Babylon's use of AI for personalized and efficient healthcare positions it uniquely in the market, suggesting a promising future.
Total Funding
$656M
- Series B (2017) $59.0M
- Series A (2016) $12.0M
- Debt Financing (2021) $30.0M
- Series C (2019-02-01) $550M
- Seed (2015-01-01) $5.9M
Investors
VNV Global Series B
Investment AB Kinnevik Series B
JamJar Investments Series A
eHealth Ventures Debt Financing
AlbaCore Capital Debt Financing
Hoxton Ventures Seed
Premium Member Intelligence
- Access details of the company management, and other intelligence on this company via Seedtable Intel